Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Mar 10;11(6):1521.
doi: 10.3390/jcm11061521.

The Nephrologist's Role in the Collaborative Multi-Specialist Network Taking Care of Patients with Diabetes on Maintenance Hemodialysis: An Overview

Affiliations
Review

The Nephrologist's Role in the Collaborative Multi-Specialist Network Taking Care of Patients with Diabetes on Maintenance Hemodialysis: An Overview

Giuseppe Cavallari et al. J Clin Med. .

Abstract

Diabetes mellitus is the leading cause of renal failure in incident dialysis patients in several countries around the world. The quality of life for patients with diabetes in maintenance hemodialysis (HD) treatment is in general poor due to disease complications. Nephrologists have to cope with all these problems because of the "total care model" and strive to improve their patients' outcome. In this review, an updated overview of the aspects the nephrologist must face in the management of these patients is reported. The conventional marker of glycemic control, hemoglobin A1c (HbA1c), is unreliable. HD itself may be responsible for dangerous hypoglycemic events. New methods of glucose control could be used even during dialysis, such as a continuous glucose monitoring (CGM) device. The pharmacological control of diabetes is another complex topic. Because of the risk of hypoglycemia, insulin and other medications used to treat diabetes may need dose adjustment. The new class of antidiabetic drugs dipeptidyl peptidase 4 (DPP-4) inhibitors can safely be used in non-insulin-dependent end-stage renal disease (ESRD) patients. Nephrologists should take care to improve the hemodynamic tolerance to HD treatment, frequently compromised by the high level of ultrafiltration needed to counter high interdialytic weight gain. Kidney and pancreas transplantation, in selected patients with diabetes, is the best therapy and is the only approach able to free patients from both dialysis and insulin therapy.

Keywords: diabetes; dialysis; dialysis hypotension; hemodialysis.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Schematic representation of the main conditions that, together, trigger the phenomenon of hemodynamic instability during HD in patients with diabetes.
Figure 2
Figure 2
The sensor is applied to the arm of a patient with a subcutaneous needle measuring interstitial glucose levels. Measurements are viewed on a receiver unit (either a smartphone or dedicated receiver unit). This model is a FreeStyle Libre.

Similar articles

Cited by

References

    1. Boenink R., Astley M.E., Huijben J.A., Stel V.S., Kerschbaum J., Rosenberg-Ots M., Asberg A.A., Lopot F., Golan E., Castro de la Nuez P., et al. The ERA Registry Annual Report 2019: Summary and age comparisons. Clin. Kidney J. 2021;15:sfab273. doi: 10.1093/ckj/sfab273. - DOI - PMC - PubMed
    1. Johnson D.W., Craven A., Isbel N.M. Modification of cardiovascular risk in hemodialysis patients: An evidence-based review. Hemodial. Int. 2007;11:1–14. doi: 10.1111/j.1542-4758.2007.00146.x. - DOI - PubMed
    1. Sands J.J., Usvyat L.A., Sullivan T., Segal J.H., Zabetakis P., Kotanko P., Maddux F.W., Diaz-Buxo J.A. Intradialytic hypotension: Frequency, sources of variation and correlation with clinical outcome. Hemodial. Int. 2014;18:415–422. doi: 10.1111/hdi.12138. - DOI - PubMed
    1. London G.M. Cardiovascular disease in chronic renal failure: Pathophysiologic aspects. Semin. Dial. 2003;16:85–94. doi: 10.1046/j.1525-139X.2003.16023.x. - DOI - PubMed
    1. Nitta K., Iimuro S., Imai E., Matsuo S., Makino H., Akizawa T., Watanabe T., Ohashi Y., Hishida A. Risk factors for increased left ventricular hypertrophy in patients with chronic kidney disease. Clin. Exp. Nephrol. 2013;17:730–742. doi: 10.1007/s10157-012-0758-4. - DOI - PMC - PubMed

LinkOut - more resources